During the recent session, Sanofi ADR (NASDAQ:SNY)’s traded shares were 1.79 million, with the beta value of the company hitting 0.51. At the last check today, the stock’s price was $49.77, reflecting an intraday loss of -4.93% or -$2.58. The 52-week high for the SNY share is $60.12, that puts it down -20.8 from that peak though still a striking 7.98% gain since the share price plummeted to a 52-week low of $45.80. The company’s market capitalization is $121.26B, and the average intraday trading volume over the past 10 days was 2.05 million shares, and the average trade volume was 2.92 million shares over the past three months.
Sanofi ADR (SNY) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.62. SNY has a Sell rating from 0 analyst(s) out of 5 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it.
Sanofi ADR (NASDAQ:SNY) trade information
Sanofi ADR (SNY) registered a -4.93% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.93% in intraday trading to $49.77, hitting a weekly high. The stock’s 5-day price performance is -5.22%, and it has moved by -9.43% in 30 days. Based on these gigs, the overall price performance for the year is 3.82%. The short interest in Sanofi ADR (NASDAQ:SNY) is 3.69 million shares and it means that shorts have 1.21 day(s) to cover.
The consensus price target of analysts on Wall Street is $60, which implies an increase of 17.05% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $48.07 and $64 respectively. As a result, SNY is trading at a discount of -28.59% off the target high and 3.42% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 13.05%. While earnings are projected to return 23.12% in 2025, the next five years will return 12.93% per annum.
SNY Dividends
Sanofi ADR is due to release its next quarterly earnings on 2025-Apr-23. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Sanofi ADR is 2.21, with the dividend yield indicating at 4.44 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 3.72%.
Sanofi ADR (NASDAQ:SNY)’s Major holders
Sanofi ADR insiders own 0.00% of total outstanding shares while institutional holders control 10.49%, with the float percentage being 10.49%. DODGE & COX is the largest shareholder of the company, while 925.0 institutions own stock in it. As of 2024-06-30, the company held over 77.11 million shares (or 6.1717% of all shares), a total value of $3.74 billion in shares.
The next largest institutional holding, with 15.21 million shares, is of FMR LLC’s that is approximately 1.2177% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $738.2 million.
Also, the Mutual Funds coming in first place with the largest holdings of Sanofi ADR (SNY) shares are Dodge & Cox Funds-Dodge & Cox Stock Fund and WASHINGTON MUTUAL INVESTORS FUND . Data provided on Mar 31, 2025 indicates that Dodge & Cox Funds-Dodge & Cox Stock Fund owns about 56.02 shares. This amounts to just over 21.02 percent of the company’s overall shares, with a $2.78 billion market value. The same data shows that the other fund manager holds slightly less at 7.74, or about 2.90% of the stock, which is worth about $384.14 million.
